



	Questions : Lok Sabha




























Screen Reader Access
Skip to Main Content
Skip to Navigation



Text Size

                                A

                                A
A















हिन्दी मे








Parliament of India Lok Sabha House of the
                        People






* Special Characters not allowed












India Time 


Your Time 


                        Tuesday,
                        12 April 2022









HomeMembersSitting MembersMembers Home PageMembers' PortalContact DetailsMembers SearchStatistical AnalysisAttendance of MembersHandbook Members Since 1952Digitized Who's WhoOthers BusinessProvisional CalendarList of BusinessPapers to be LaidList of Private Members' BusinessBulletin-IDigitized Lok Sabha Bulletin Part IBulletin-IIStatement of WorkSpecial Mentions (ZERO HOUR)Resume of WorkDigitized Resume of Work done by Lok Sabha QuestionsHomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions DebatesIntroductionSynopsisUncorrected DebateText of DebateDigitized DebatesConstituent Assembly DebatesWit And HumourDebate SearchHindi FontsDisclaimer Papers LaidPapers Laid on the Table of the House LegislationIntroduction(How Bill Becomes Act)Bills IntroducedBills PassedBills PendingBills AssentedBills LapsedBills WithdrawnBills NegativedBills Search Disclaimer CommitteesIntroductionChairpersonSummary of WorkCommittee Meetings ScheduleBills Referred to CommitteesReports PresentedDigitized ReportsPress ReleaseMembership SearchToday's Committee MeetingsCommittee Subject SelectedDepartment Related-RS Govt. AssurancesSANSAD TVIntranet





HomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions











Download as PDF




Print












PDF/WORD(Hindi)


PDF/WORD




                                    GOVERNMENT OF INDIA
                                





                                    MINISTRY OF
                                    HEALTH AND FAMILY WELFARE






                                    LOK SABHA
                                





UNSTARRED 


                                    QUESTION NO:
                                

1111






                                    ANSWERED ON: 
                                

03.12.2021






Manufacturing of COVID-19 Vaccines




 Dr. T. Sumathy (a) Thamizhachi Thangapandian













                                                    D. M. Kathir Anand
                                                












                        Will the Minister of





HEALTH AND FAMILY WELFARE


                        be pleased to state:-















                                                    (a) whether the Government has ascertained that the two approved COVID-19 vaccine manufacturers of Covishield and Covaxin have achieved the optimum production capacity, if so, the details thereof;(b) whether the Government or Indian Council of Medical Research has approved any other companies other than the said two companies to manufacture and produce COVID-19 vaccines in India;(c) if so, the details thereof and if not, the reasons therefor;(d) whether the Central Drugs Standard Control Organisation (CDSCO) has granted import permission/ license for importing and manufacturing of COVID-19 Vaccines to meet the demand in the country; and(e) if so, the details of the permission granted and the total number and quantum of vaccines expected through this arrangement?






ANSWER




                                                        THE MINISTER OF STATE IN THE MINISTRY OF HEALTH AND FAMILY WELFARE(DR. BHARATI PRAVIN PAWAR)(a) ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant) (COVISHIELD) is manufactured by M/s Serum Institute of India Pvt., Ltd., Pune, while the Whole Virion Inactivated Corona Virus Vaccine (COVAXIN) is manufactured by M/s Bharat Biotech International Limited, Hyderabad.          As communicated by the M/s Serum Institute of India, the current monthly vaccine production capacity of Covishield is approx. 250-275 Million doses per month.Further, as communicated by M/s Bharat Biotech International Limited, Hyderabad, the current monthly vaccine production capacity of Covaxin is approx. 50-60 Million doses/month. Both companies have achieved close to 90% of present production capacity.(b) to (e): As per the provisions of New Drugs and Clinical Trials Rules, 2019 under Drugs and Cosmetics Act, 1940 and in light of urgent need due to COVID pandemic in the country, CDSCO has granted permissions to following COVID-19 vaccines other than COVAXIN & COVISHIELD for prevention of COVID-19 for restricted use in emergency situation:Permission For Manufacture of COVID-19 vaccines:1.	Gam-COVID-Vac Combined vector vaccine [SPUTNIK-V] manufactured by M/s Ra (biologicals), Panacea Biotec Ltd., New Delhi using imported Ready to Fill (RTF) bulk from M/s Generium JSC, Russia on 02.07.2021.2.	Novel Corona Virus 2019-nCoV vaccine [ZyCoV-D] manufactured by M/s Cadila Healthcare Limited, Ahmedabad on 20.08.2021.3.	Ad26.COV2-S (recombinant) COVID-19 Vaccine manufactured by M/s Biological E limited, Hyderabad using imported bulk of M/s Johnson & Johnson Pvt. Ltd on 18.08.2021.4.	Gam-COVID-Vac Combined vector vaccine [Sputnik–V] manufactured under technology transfer from M/s RDIF, Russia by M/s Hetero Biopharma Limited, Hyderabad on 07.10.2021.Permission For Import of COVID-19 Vaccines:1.	Gam-COVID-Vac Combined vector vaccine [SPUTNIK-V] to M/s Dr. Reddy’s Laboratories Ltd, Hyderabad on 12.04.2021.2.	mRNA-1273 COVID-19 vaccine (Moderna) to M/s Cipla Limited, Mumbai on 29.06.2021.3.	Ad26.COV2-S (recombinant) COVID-19 Vaccine to M/s Johnson & Johnson Pvt. Ltd., Mumbai on 07.08.2021.*******
























HomeArchiveIndex to Select Questions (1984-1999)Ballot ListStatistical Statements Relating to QuestionsUploading of Questions - Status QueryProcedure for Sending Text of Questions & AnswersDemarcation of responsibilities in Govt. of IndiaBrochure on Statutory Corporations, Companies and Other Bodies in Which the Government of India have financial or controlling interestHighlights pertaining to questions of 17th Lok Sabha






Contact Us 
Disclaimer











        Developed and Hosted by National Informatics Centre (NIC)

Content on this website is published,
            managed & maintained by Software Unit, Computer (HW & SW) Management. Branch,
            Lok Sabha Secretariat





HomeMembersBusinessQuestionsDebatesPapers Laid


LegislationCommitteesSANSAD TVIntranetSecretariatPRIDE


RecruitmentSC/ST ReservationConferenceParliament Library


About ParliamentPhoto GalleryRelated LinksRTITendersFAQ


SpeakerDy. SpeakerLeader of the HousePanel of ChairpersonsContact UsFeedback


Council of MinistersPublications of MinistriesParliamentry ProceduresJournal of Parliamentary Information
Visitor's Counter:113224397







Copyright
Privacy Policy
Disclaimer
Terms &
                Conditions

                Accessibility Statement
Accessibility
                Options
Feedback
Site Map







